Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 684

1.

Utility of Contrast-Enhanced Ultrasound for Early Therapeutic Evaluation of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization.

Watanabe Y, Ogawa M, Kumagawa M, Hirayama M, Miura T, Matsumoto N, Nakagawara H, Yamamoto T, Moriyama M.

J Ultrasound Med. 2019 Aug 22. doi: 10.1002/jum.15118. [Epub ahead of print]

PMID:
31436341
2.

Natural History of Pancreatic Ductal Adenocarcinoma Diagnosed During Observation of Other Organ Cancers.

Okagawa Y, Kondo T, Tsuji Y, Takayama T, Oiwa S, Yoshida M, Ihara H, Sumiyoshi T, Hirayama M, Kondo H.

Am J Case Rep. 2019 Jul 23;20:1080-1084. doi: 10.12659/AJCR.917197.

3.

Role of microRNAs in glucocorticoid‑resistant B‑cell precursor acute lymphoblastic leukemia.

Sakurai N, Komada Y, Hanaki R, Morimoto M, Ito T, Nakato D, Hirayama M.

Oncol Rep. 2019 Aug;42(2):708-716. doi: 10.3892/or.2019.7191. Epub 2019 Jun 10.

PMID:
31233193
4.

Personalized pharmacokinetic targeting with busulfan in allogeneic hematopoietic stem cell transplantation in infants with acute lymphoblastic leukemia.

Takachi T, Arakawa Y, Nakamura H, Watanabe T, Aoki Y, Ohshima J, Takahashi Y, Hirayama M, Miyamura T, Sugita K, Koh K, Horibe K, Ishii E, Mizutani S, Tomizawa D.

Int J Hematol. 2019 Sep;110(3):355-363. doi: 10.1007/s12185-019-02684-0. Epub 2019 Jun 14.

PMID:
31201644
5.

HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma.

Sakata J, Hirosue A, Yoshida R, Kawahara K, Matsuoka Y, Yamamoto T, Nakamoto M, Hirayama M, Takahashi N, Nakamura T, Arita H, Nakashima H, Nagata M, Hiraki A, Shinohara M, Nakayama H.

Int J Mol Sci. 2019 May 19;20(10). pii: E2473. doi: 10.3390/ijms20102473.

6.

ENIGMA: an enterotype-like unigram mixture model for microbial association analysis.

Abe K, Hirayama M, Ohno K, Shimamura T.

BMC Genomics. 2019 Apr 4;20(Suppl 2):191. doi: 10.1186/s12864-019-5476-9.

7.

An Unusual Presentation of Nasopharyngeal Carcinoma as Lemierre Syndrome.

Ito T, Majima H, Ozawa T, Maeda M, Iwamoto S, Hirayama M, Azuma E.

Am J Case Rep. 2019 Feb 28;20:263-267. doi: 10.12659/AJCR.913755.

8.

Inhalation of hydrogen gas elevates urinary 8-hydroxy-2'-deoxyguanine in Parkinson's disease.

Hirayama M, Ito M, Minato T, Yoritaka A, LeBaron TW, Ohno K.

Med Gas Res. 2019 Jan 9;8(4):144-149. doi: 10.4103/2045-9912.248264. eCollection 2018 Oct-Dec.

9.

CD3+ B-1a Cells as a Mediator of Disease Progression in Autoimmune-Prone Mice.

Yamamoto W, Toyoda H, Xu DQ, Hanaki R, Morimoto M, Nakato D, Ito T, Iwamoto S, Bonno M, Tanaka S, Hirayama M.

Mediators Inflamm. 2018 Dec 23;2018:9289417. doi: 10.1155/2018/9289417. eCollection 2018.

10.

Strong-correlation induced high-mobility electrons in Dirac semimetal of perovskite oxide.

Fujioka J, Yamada R, Kawamura M, Sakai S, Hirayama M, Arita R, Okawa T, Hashizume D, Hoshino M, Tokura Y.

Nat Commun. 2019 Jan 21;10(1):362. doi: 10.1038/s41467-018-08149-y.

11.

Effect of Yokukansan on Nitric Oxide Production and Hydroxyl Radical Metabolism During Cerebral Ischemia and Reperfusion in Mice.

Kitabayashi C, Ito Y, Kawasaki H, Tanaka A, Nishioka R, Yamazato M, Ishizawa K, Nagai T, Hirayama M, Takahashi K, Yamamoto T, Araki N.

J Stroke Cerebrovasc Dis. 2019 May;28(5):1151-1159. doi: 10.1016/j.jstrokecerebrovasdis.2018.12.047. Epub 2019 Jan 14.

PMID:
30655039
12.

A latent allocation model for the analysis of microbial composition and disease.

Abe K, Hirayama M, Ohno K, Shimamura T.

BMC Bioinformatics. 2018 Dec 31;19(Suppl 19):519. doi: 10.1186/s12859-018-2530-6.

13.

Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's disease.

Suzuki A, Ito M, Hamaguchi T, Mori H, Takeda Y, Baba R, Watanabe T, Kurokawa K, Asakawa S, Hirayama M, Ohno K.

PLoS One. 2018 Dec 26;13(12):e0208313. doi: 10.1371/journal.pone.0208313. eCollection 2018.

14.

Collision tumour of extramammary Paget disease and melanoma.

Mae K, Irisawa R, Saito M, Kato Y, Hirayama M, Tsuboi R, Harada K.

Clin Exp Dermatol. 2019 Apr;44(3):e61-e62. doi: 10.1111/ced.13854. Epub 2018 Dec 11. No abstract available.

PMID:
30548298
15.

Infantile bullous pemphigoid successfully treated with i.v. immunoglobulin and cyclosporin.

Okada K, Kakeda M, Yamamoto S, Yokoyama T, Habe K, Nakato D, Hirayama M, Mizutani H, Yamanaka K.

J Dermatol. 2019 Jun;46(6):e213-e214. doi: 10.1111/1346-8138.14726. Epub 2018 Dec 7. No abstract available.

PMID:
30536915
16.

Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.

Takada A, Ii N, Hirayama M, Toyoda H, Matsubara T, Toyomasu Y, Kawamura T, Daimon T, Sakuma H, Nomoto Y.

J Neurosurg Pediatr. 2018 Nov 23;23(3):317-324. doi: 10.3171/2018.9.PEDS18181.

PMID:
30497152
17.

Advances in Functional Restoration of the Lacrimal Glands.

Hirayama M.

Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES174-DES182. doi: 10.1167/iovs.17-23528. Review.

PMID:
30481824
18.

Phonon Angular Momentum Induced by the Temperature Gradient.

Hamada M, Minamitani E, Hirayama M, Murakami S.

Phys Rev Lett. 2018 Oct 26;121(17):175301. doi: 10.1103/PhysRevLett.121.175301.

PMID:
30411957
20.

Discontinuation of NTBC after liver transplantation in tyrosinemia type 1.

Kurihara K, Toyoda H, Amoano K, Inoue M, Uchida K, Sakurai H, Hayashi A, Hirayama M.

Pediatr Int. 2018 Nov;60(11):1039-1041. doi: 10.1111/ped.13697. Epub 2018 Oct 30. No abstract available.

PMID:
30375135
21.

Cas9 ribonucleoprotein complex allows direct and rapid analysis of coding and noncoding regions of target genes in Pleurodeles waltl development and regeneration.

Suzuki M, Hayashi T, Inoue T, Agata K, Hirayama M, Suzuki M, Shigenobu S, Takeuchi T, Yamamoto T, Suzuki KT.

Dev Biol. 2018 Nov 15;443(2):127-136. doi: 10.1016/j.ydbio.2018.09.008. Epub 2018 Sep 10.

PMID:
30213538
22.

Endoscopic submucosal dissection for early squamous cell carcinoma in the anal canal and Lugol chromoendoscopy for assessment of the lateral margin.

Uozumi T, Sumiyoshi T, Kondo H, Minagawa T, Fujii R, Yosida M, Tokuchi K, Mizukami T, Morita K, Ihara H, Okagawa Y, Takayama T, Ooiwa S, Hirayama M, Oyamada Y.

Endosc Int Open. 2018 Sep;6(9):E1130-E1133. doi: 10.1055/a-0584-7060. Epub 2018 Sep 11.

23.

Randomized, double-blind, multicenter trial of hydrogen water for Parkinson's disease.

Yoritaka A, Ohtsuka C, Maeda T, Hirayama M, Abe T, Watanabe H, Saiki H, Oyama G, Fukae J, Shimo Y, Hatano T, Kawajiri S, Okuma Y, Machida Y, Miwa H, Suzuki C, Kazama A, Tomiyama M, Kihara T, Hirasawa M, Shimura H, Oda E, Ito M, Ohno K, Hattori N.

Mov Disord. 2018 Sep;33(9):1505-1507. doi: 10.1002/mds.27472. Epub 2018 Sep 12. No abstract available.

PMID:
30207619
24.

Organisational barriers to and facilitators for female surgeons' career progression: a systematic review.

Hirayama M, Fernando S.

J R Soc Med. 2018 Sep;111(9):324-334. doi: 10.1177/0141076818790661. Epub 2018 Sep 3.

25.

Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study.

Ohnuma H, Sato Y, Hayasaka N, Matsuno T, Fujita C, Sato M, Osuga T, Hirakawa M, Miyanishi K, Sagawa T, Fujikawa K, Ohi M, Okagawa Y, Tsuji Y, Hirayama M, Ito T, Nobuoka T, Takemasa I, Kobune M, Kato J.

Cancer Sci. 2018 Nov;109(11):3554-3563. doi: 10.1111/cas.13772. Epub 2018 Sep 25.

26.

Atypical presentation of a cushion sign-positive stomach gastrointestinal stromal tumor with cystic formation: A case report.

Okagawa Y, Sumiyoshi T, Ihara H, Oiwa S, Tokuchi K, Yoshida M, Fujii R, Minagawa T, Morita K, Hirayama M, Kondo H, Oyamada Y, Kawarada Y, Kitashiro S, Okushiba S.

Mol Clin Oncol. 2018 Aug;9(2):168-172. doi: 10.3892/mco.2018.1639. Epub 2018 May 25.

27.

Clinical and Imaging Features of Multiple System Atrophy: Challenges for an Early and Clinically Definitive Diagnosis.

Watanabe H, Riku Y, Hara K, Kawabata K, Nakamura T, Ito M, Hirayama M, Yoshida M, Katsuno M, Sobue G.

J Mov Disord. 2018 Sep;11(3):107-120. doi: 10.14802/jmd.18020. Epub 2018 Aug 9.

28.

Weekly Rituximab Followed by Monthly Rituximab Treatment for Autoimmune Disease Associated With RAS-associated Autoimmune Leukoproliferative Disease.

Toyoda H, Deguchi T, Iwamoto S, Kihira K, Hori H, Komada Y, Hirayama M.

J Pediatr Hematol Oncol. 2018 Nov;40(8):e516-e518. doi: 10.1097/MPH.0000000000001276.

PMID:
30080751
29.

Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab: comment.

Matsumoto T, Wada H, Toyoda H, Hirayama M, Yamashita Y, Katayama N.

J Thromb Haemost. 2018 Jun 7. doi: 10.1111/jth.14190. [Epub ahead of print] No abstract available.

PMID:
29877044
30.

[Obstacles to return to work: Translation and cross-cultural adaptation of the questionnaire to the Brazilian context].

Milani D, Souza AC, Hirayama MS, Alexandre NMC.

Cien Saude Colet. 2018 May;23(5):1387-1401. doi: 10.1590/1413-81232018235.17152016. Portuguese.

31.

Clinical Manifestation of Patients With Atypical Hemolytic Uremic Syndrome With the C3 p.I1157T Variation in the Kinki Region of Japan.

Matsumoto T, Toyoda H, Amano K, Hirayama M, Ishikawa E, Fujimoto M, Ito M, Ohishi K, Katayama N, Yoshida Y, Matsumoto M, Kawamura N, Ikejiri M, Kawakami K, Miyata T, Wada H.

Clin Appl Thromb Hemost. 2018 Nov;24(8):1301-1307. doi: 10.1177/1076029618771750. Epub 2018 Apr 25.

32.

Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agents.

Kojima T, Asano Y, Kurasawa O, Hirata Y, Iwamura N, Wong TT, Saito B, Tanaka Y, Arai R, Yonemori K, Miyamoto Y, Sagiya Y, Yaguchi M, Shibata S, Mizutani A, Sano O, Adachi R, Satomi Y, Hirayama M, Aoyama K, Hiura Y, Kiba A, Kitamura S, Imamura S.

Bioorg Med Chem. 2018 May 15;26(9):2452-2465. doi: 10.1016/j.bmc.2018.04.008. Epub 2018 Apr 4.

PMID:
29669694
33.

Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4+ T cells expressing converged T-cell receptor genes in vitro.

Tsuruta M, Ueda S, Yew PY, Fukuda I, Yoshimura S, Kishi H, Hamana H, Hirayama M, Yatsuda J, Irie A, Senju S, Yuba E, Kamba T, Eto M, Nakayama H, Nishimura Y.

Oncoimmunology. 2018 Jan 5;7(4):e1415687. doi: 10.1080/2162402X.2017.1415687. eCollection 2018.

34.

Induction of MEK/ERK activity by AZD8055 confers acquired resistance in neuroblastoma.

Xu DQ, Toyoda H, Qi L, Morimoto M, Hanaki R, Iwamoto S, Komada Y, Hirayama M.

Biochem Biophys Res Commun. 2018 May 15;499(3):425-432. doi: 10.1016/j.bbrc.2018.03.143. Epub 2018 Mar 30.

PMID:
29571732
35.

Experimental Determination of the Topological Phase Diagram in Cerium Monopnictides.

Kuroda K, Ochi M, Suzuki HS, Hirayama M, Nakayama M, Noguchi R, Bareille C, Akebi S, Kunisada S, Muro T, Watson MD, Kitazawa H, Haga Y, Kim TK, Hoesch M, Shin S, Arita R, Kondo T.

Phys Rev Lett. 2018 Feb 23;120(8):086402. doi: 10.1103/PhysRevLett.120.086402.

PMID:
29543003
36.

Anti-tumor effect of AZD8055 against neuroblastoma cells in vitro and in vivo.

Xu DQ, Toyoda H, Yuan XJ, Qi L, Chelakkot VS, Morimoto M, Hanaki R, Kihira K, Hori H, Komada Y, Hirayama M.

Exp Cell Res. 2018 Apr 15;365(2):177-184. doi: 10.1016/j.yexcr.2018.02.032. Epub 2018 Feb 28.

PMID:
29499203
37.

Restoration of a Conduction Block after the Long-term Treatment of CIDP with Anti-neurofascin 155 Antibodies: Follow-up of a Case over 23 Years.

Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Atsuta N, Nakamura T, Hirayama M, Ogata H, Yamasaki R, Kira JI, Katsuno M, Sobue G.

Intern Med. 2018 Jul 15;57(14):2061-2066. doi: 10.2169/internalmedicine.0455-17. Epub 2018 Feb 28.

38.

Integrated molecular profiling of juvenile myelomonocytic leukemia.

Murakami N, Okuno Y, Yoshida K, Shiraishi Y, Nagae G, Suzuki K, Narita A, Sakaguchi H, Kawashima N, Wang X, Xu Y, Chiba K, Tanaka H, Hama A, Sanada M, Ito M, Hirayama M, Watanabe A, Ueno T, Kojima S, Aburatani H, Mano H, Miyano S, Ogawa S, Takahashi Y, Muramatsu H.

Blood. 2018 Apr 5;131(14):1576-1586. doi: 10.1182/blood-2017-07-798157. Epub 2018 Feb 2.

39.

Effects of Memantine on Nitric Oxide Production and Hydroxyl Radical Metabolism during Cerebral Ischemia and Reperfusion in Mice.

Tanaka A, Ito Y, Kawasaki H, Kitabayashi C, Nishioka R, Yamazato M, Ishizawa K, Nagai T, Hirayama M, Takahashi K, Yamamoto T, Araki N.

J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1609-1615. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.014.

PMID:
29426680
40.

Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson's disease.

Kawabata K, Watanabe H, Hara K, Bagarinao E, Yoneyama N, Ogura A, Imai K, Masuda M, Yokoi T, Ohdake R, Tanaka Y, Tsuboi T, Nakamura T, Hirayama M, Ito M, Atsuta N, Maesawa S, Naganawa S, Katsuno M, Sobue G.

J Neurol. 2018 Mar;265(3):688-700. doi: 10.1007/s00415-018-8755-5. Epub 2018 Feb 1.

PMID:
29392456
41.

All-Solid-State Batteries with Thick Electrode Configurations.

Kato Y, Shiotani S, Morita K, Suzuki K, Hirayama M, Kanno R.

J Phys Chem Lett. 2018 Feb 1;9(3):607-613. doi: 10.1021/acs.jpclett.7b02880. Epub 2018 Jan 22.

PMID:
29338266
42.

Detection of Fucoidan in Urine after Oral Intake of Traditional Japanese Seaweed, Okinawa mozuku (Cladosiphon okamuranus Tokida).

Tokita Y, Hirayama M, Nakajima K, Tamaki K, Iha M, Nagamine T.

J Nutr Sci Vitaminol (Tokyo). 2017;63(6):419-421. doi: 10.3177/jnsv.63.419.

43.

Severe hyposmia and aberrant functional connectivity in cognitively normal Parkinson's disease.

Yoneyama N, Watanabe H, Kawabata K, Bagarinao E, Hara K, Tsuboi T, Tanaka Y, Ohdake R, Imai K, Masuda M, Hattori T, Ito M, Atsuta N, Nakamura T, Hirayama M, Maesawa S, Katsuno M, Sobue G.

PLoS One. 2018 Jan 5;13(1):e0190072. doi: 10.1371/journal.pone.0190072. eCollection 2018.

44.

Pharmacokinetics and Pharmacodynamics of Azeloprazole Sodium, a Novel Proton Pump Inhibitor, in Healthy Japanese Volunteers.

Toda R, Shiramoto M, Komai E, Yoshii K, Hirayama M, Kawabata Y.

J Clin Pharmacol. 2018 Apr;58(4):425-433. doi: 10.1002/jcph.1038. Epub 2017 Nov 28.

PMID:
29193126
45.

Strategies for Regenerating the Lacrimal Gland.

Liu CY, Hirayama M, Ali M, Shah D, Aakalu VK.

Curr Ophthalmol Rep. 2017 Sep;5(3):193-198. doi: 10.1007/s40135-017-0142-3. Epub 2017 May 29.

46.

Mass balance and metabolism of Z-215, a novel proton pump inhibitor, in healthy volunteers.

Toda R, Miyagawa T, Masuda Y, Hoshino Y, Yoshii K, Hirayama M, Shibuya M, Kawabata Y.

Xenobiotica. 2018 Oct;48(10):1006-1020. doi: 10.1080/00498254.2017.1390625. Epub 2017 Nov 2.

PMID:
29092680
47.

Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study.

Minato T, Maeda T, Fujisawa Y, Tsuji H, Nomoto K, Ohno K, Hirayama M.

PLoS One. 2017 Nov 1;12(11):e0187307. doi: 10.1371/journal.pone.0187307. eCollection 2017.

48.

A Heterozygous CFHR3-CFHR1 Gene Deletion in a Pediatric Patient With Transplant-associated Thrombotic Microangiopathy Who was Treated With Eculizumab.

Nozawa A, Ozeki M, Hori T, Kawamoto N, Hirayama M, Azuma E, Fukao T.

J Pediatr Hematol Oncol. 2018 Nov;40(8):e544-e546. doi: 10.1097/MPH.0000000000000986.

PMID:
28991129
49.

A Ligation of the Lacrimal Excretory Duct in Mouse Induces Lacrimal Gland Inflammation with Proliferative Cells.

Liu Y, Hirayama M, Kawakita T, Tsubota K.

Stem Cells Int. 2017;2017:4923426. doi: 10.1155/2017/4923426. Epub 2017 Aug 10.

50.

One-step lipid extraction for plasma lipidomics analysis by liquid chromatography mass spectrometry.

Satomi Y, Hirayama M, Kobayashi H.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Sep 15;1063:93-100. doi: 10.1016/j.jchromb.2017.08.020. Epub 2017 Aug 19.

PMID:
28850891

Supplemental Content

Loading ...
Support Center